Imunon, Inc. (IMNN) stock

IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30

$0.63−0.01 (-1.22%)

Close on Nov 13, 2026Market cap $3.53MP/E –Yield –

Imunon gross margin

Gross margin is gross profit as a percentage of revenue.

Imunon has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?